STAGE International Speaker Seminar Series (ISSS) with Clare Turnbull

May 7, 2021
|
12:00pm–1:00pm
Workshop/Seminar
Details

Breast Cancer Susceptibility Genetics: expansion of testing and emerging challenges

Clare is Professor of Translational Cancer Genetics in the Division of Genetics and Epidemiology at the Institute of Cancer Research.   Her research spans statistical, population and public-health-related analyses of genetic cancer susceptibility and implementation of expanded genomic testing.  She is currently rolling out a new £4.3 million CRUK-funded program: ‘CanGene-CanVar: Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer’ program.  As an honorary consultant in Public Health, she is working closely with Public Health England in this program to incorporate genomic data into the National Cancer Registration datasets.  She is also in process of initiating BRCA-DIRECT: a CRUK-funded program to develop and pilot a digital platform to deliver Rapid, Digital, Clinician-Independent, Genetic Susceptibility Biomarker Testing.  Undertaking studies in various tumour types of germline, somatic and functional genomics, Clare has a particular interest in testicular cancer.  From 2014 to 2020, Clare worked as Clinical Lead for Cancer Genomics for the Genomics England 100,000 Genomes Project.  Having trained as a Clinical Geneticist, her clinical work at The Royal MarsdenNHS Foundation Trust focuses on management of patients and families with genetic susceptibility to cancer. 

Clare undertook her preclinical training in Cambridge and qualified in medicine from Oxford University.  She undertook general medical training across hospitals in Oxford and London and specialist training in Clinical Genetics in London. She completed a PhD in Genetic Epidemiology and Molecular Genetics at the Institute of Cancer Research, London and a Masters degree in Epidemiology and Statistics at the London School of Hygiene.  She is a member by distinction of the Faculty of Public Health Medicine.

For more information, visit https://canssiontario.utoronto.ca/event/stage_isss_clare_turnbull/

Location
Virtual
Contact
416-689-7271
2021-05-07 16:00:00 2021-05-07 17:00:00 UTC STAGE International Speaker Seminar Series (ISSS) with Clare Turnbull Breast Cancer Susceptibility Genetics: expansion of testing and emerging challenges Clare is Professor of Translational Cancer Genetics in the Division of Genetics and Epidemiology at the Institute of Cancer Research.   Her research spans statistical, population and public-health-related analyses of genetic cancer susceptibility and implementation of expanded genomic testing.  She is currently rolling out a new £4.3 million CRUK-funded program: ‘CanGene-CanVar: Data Resources, Clinical and Educational Tools to leverage Cancer Susceptibility Genetics for Early Detection and Prevention of Cancer’ program.  As an honorary consultant in Public Health, she is working closely with Public Health England in this program to incorporate genomic data into the National Cancer Registration datasets.  She is also in process of initiating BRCA-DIRECT: a CRUK-funded program to develop and pilot a digital platform to deliver Rapid, Digital, Clinician-Independent, Genetic Susceptibility Biomarker Testing.  Undertaking studies in various tumour types of germline, somatic and functional genomics, Clare has a particular interest in testicular cancer.  From 2014 to 2020, Clare worked as Clinical Lead for Cancer Genomics for the Genomics England 100,000 Genomes Project.  Having trained as a Clinical Geneticist, her clinical work at The Royal MarsdenNHS Foundation Trust focuses on management of patients and families with genetic susceptibility to cancer.  Clare undertook her preclinical training in Cambridge and qualified in medicine from Oxford University.  She undertook general medical training across hospitals in Oxford and London and specialist training in Clinical Genetics in London. She completed a PhD in Genetic Epidemiology and Molecular Genetics at the Institute of Cancer Research, London and a Masters degree in Epidemiology and Statistics at the London School of Hygiene.  She is a member by distinction of the Faculty of Public Health Medicine. For more information, visit https://canssiontario.utoronto.ca/event/stage_isss_clare_turnbull/ Virtual esther.berzunza@utoronto.ca